Table 1 General characteristics of the study patients at baseline
From: Outcome of patients with septic shock and high-dose vasopressor therapy
Variables | All (n = 106) | Survivors at day 28 (n = 42) | Non-survivors at day 28 (n = 64) | p |
|---|---|---|---|---|
Age (years), mean ± SD | 62 ± 16 | 63 ± 14 | 59 ± 19 | 0.81 |
Sex [n (%)] | ||||
Males | 75 (70.8) | 32 (76.2) | 43 (67.2) | 0.32 |
Comorbidities [n (%)] | ||||
Immunosuppression | 35 (33) | 12 (28.6) | 23 (35.9) | 0.43 |
Cardiovascular disease | 31 (29.2) | 12 (28.6) | 19 (29.7) | 0.90 |
Respiratory disease | 17 (16) | 7 (16.7) | 10 (15.6) | 0.36 |
Renal disease | 14 (13.2) | 5 (11.9) | 9 (14.1) | 0.75 |
Obesity | 15 (14.2) | 8 (19.0) | 7 (10.9) | 0.24 |
Cirrhosis | 12 (11.3) | 1 (2.4) | 11 (17.2) | 0.03 |
Diabetes mellitus | 30 (28.3) | 13 (31.0) | 17 (26.6) | 0.62 |
Source of infection [n (%)] | ||||
Community-acquired | 55 (51.9) | 25 (59.5) | 30 (46.9) | 0.20 |
Hospital-acquired | 51 (41.1) | 17 (40.5) | 34 (53.1) | 0.20 |